Determinants of survival of the bovine blastocyst to cryopreservation stress: treatment with colony stimulating factor 2 during the morula-to-blastocyst transition and embryo sex.

Blastocyst Bovine CSF2 Embryo Sex Vitrification

Journal

CABI agriculture and bioscience
ISSN: 2662-4044
Titre abrégé: CABI Agric Biosci
Pays: United States
ID NLM: 101777285

Informations de publication

Date de publication:
2020
Historique:
entrez: 21 4 2021
pubmed: 1 1 2020
medline: 1 1 2020
Statut: ppublish

Résumé

Colony-stimulating factor 2 (CSF2) is an important maternal regulator of embryonic development. Earlier research indicates that CSF2 can regulate genes involved in cellular stress responses and block apoptosis. Here, we tested whether addition of 10 ng/mL CSF2 at day 5 of development would increase the survival of blastocysts harvested at day 7 and subjected to vitrification. Additional objectives were to determine whether embryo sex affected survival or whether effects of CSF2 interacted with sex. Survival after vitrification was measured as the percent of warmed blastocysts that re-established a blastocoele after culture and that underwent hatching from the zona pellucida. In the first experiment, blastocysts were vitrified, warmed, cultured for 24 h, and DNA embryo sexing performed by PCR. There was no effect of CSF2, sex, or the interaction on the percent of blastocysts that re-expanded or that were hatching or hatched. In the second experiment, vitrified blastocysts were warmed and cultured for 24, 48, and 72 h. Treatment with CSF2 increased (P = 0.021) the percent of blastocysts that re-expanded as compared to the vehicle group (overall, 77.8 ± 4.7% vs 73.3 ± 4.7%). Percent re-expansion was highest at 24 h and declined slightly thereafter (P = 0.024). Although the interaction was not significant, the effect of CSF2 was greater at 48 and 72 h than at 24 h because CSF2 reduced the incidence of embryos collapsing after re-expansion. Furthermore, the proportion of re-expanded blastocysts at 24 h that experienced blastocoel collapse by 72 h was lower (P = 0.053) for CSF2 (3.6%; 7/195) than for vehicle (8.2%; 16/195). The percent of warmed blastocysts that were hatching or hatched increased with time (P < 0.0001) but there was no effect of CSF2 or the interaction with time on hatching. Treatment with CSF2 from day 5 to 7 of development did not cause a significant effect on the percent of blastocysts that re-established the blastocoele after 24 h of culture but CSF2 reduced the collapse of the blastocoele that occurred for a portion of the embryos that had experienced re-expansion at 24 h. Thus, CSF2 can provide protection to a proportion of blastocysts from cryodamage caused by vitrification. Further work is needed to evaluate whether CSF2 increases survival of vitrified blastocysts after embryo transfer.

Sections du résumé

BACKGROUND BACKGROUND
Colony-stimulating factor 2 (CSF2) is an important maternal regulator of embryonic development. Earlier research indicates that CSF2 can regulate genes involved in cellular stress responses and block apoptosis. Here, we tested whether addition of 10 ng/mL CSF2 at day 5 of development would increase the survival of blastocysts harvested at day 7 and subjected to vitrification. Additional objectives were to determine whether embryo sex affected survival or whether effects of CSF2 interacted with sex.
RESULTS RESULTS
Survival after vitrification was measured as the percent of warmed blastocysts that re-established a blastocoele after culture and that underwent hatching from the zona pellucida. In the first experiment, blastocysts were vitrified, warmed, cultured for 24 h, and DNA embryo sexing performed by PCR. There was no effect of CSF2, sex, or the interaction on the percent of blastocysts that re-expanded or that were hatching or hatched. In the second experiment, vitrified blastocysts were warmed and cultured for 24, 48, and 72 h. Treatment with CSF2 increased (P = 0.021) the percent of blastocysts that re-expanded as compared to the vehicle group (overall, 77.8 ± 4.7% vs 73.3 ± 4.7%). Percent re-expansion was highest at 24 h and declined slightly thereafter (P = 0.024). Although the interaction was not significant, the effect of CSF2 was greater at 48 and 72 h than at 24 h because CSF2 reduced the incidence of embryos collapsing after re-expansion. Furthermore, the proportion of re-expanded blastocysts at 24 h that experienced blastocoel collapse by 72 h was lower (P = 0.053) for CSF2 (3.6%; 7/195) than for vehicle (8.2%; 16/195). The percent of warmed blastocysts that were hatching or hatched increased with time (P < 0.0001) but there was no effect of CSF2 or the interaction with time on hatching.
CONCLUSION CONCLUSIONS
Treatment with CSF2 from day 5 to 7 of development did not cause a significant effect on the percent of blastocysts that re-established the blastocoele after 24 h of culture but CSF2 reduced the collapse of the blastocoele that occurred for a portion of the embryos that had experienced re-expansion at 24 h. Thus, CSF2 can provide protection to a proportion of blastocysts from cryodamage caused by vitrification. Further work is needed to evaluate whether CSF2 increases survival of vitrified blastocysts after embryo transfer.

Identifiants

pubmed: 33880450
doi: 10.1186/s43170-020-00012-9
pmc: PMC8055050
mid: NIHMS1684320
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD088352
Pays : United States

Déclaration de conflit d'intérêts

Competing interests The authors declare that they have no competing interests.

Références

FASEB J. 2014 Sep;28(9):3975-86
pubmed: 24858280
BMC Genomics. 2016 Jan 22;17:72
pubmed: 26801242
Theriogenology. 2006 May;65(8):1551-62
pubmed: 16229883
J Reprod Immunol. 1999 Mar;42(2):135-45
pubmed: 10221736
Theriogenology. 2018 Mar 1;108:127-135
pubmed: 29207293
Biol Reprod. 2001 Apr;64(4):1206-15
pubmed: 11259269
J Dairy Sci. 2018 Jan;101(1):690-704
pubmed: 29128220
Endocrinology. 2009 Nov;150(11):5046-54
pubmed: 19797121
Reprod Domest Anim. 2020 Jun;55(6):659-676
pubmed: 32144939
Hum Reprod. 1999 Dec;14(12):3069-76
pubmed: 10601098
PLoS One. 2019 Oct 10;14(10):e0223570
pubmed: 31600298
Reprod Biomed Online. 2007 Jan;14(1):96-101
pubmed: 17207341
Theriogenology. 2001 Jun 1;55(9):1843-53
pubmed: 11414489
Physiol Genomics. 2008 Jan 17;32(2):264-72
pubmed: 17986520
Am J Reprod Immunol. 2011 Jun;65(6):578-88
pubmed: 21223422
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3394-9
pubmed: 20133684
Hum Reprod. 2009 Dec;24(12):2997-3009
pubmed: 19737804
Mol Reprod Dev. 2005 Oct;72(2):201-7
pubmed: 15968626
Mech Dev. 2016 Feb;139:42-50
pubmed: 26752320
Theriogenology. 2016 Mar 1;85(4):591-600
pubmed: 26506912
Theriogenology. 2019 Jul 15;133:135-143
pubmed: 31091484
Mol Reprod Dev. 2002 Feb;61(2):234-48
pubmed: 11803560
Theriogenology. 2012 Apr 1;77(6):1186-97
pubmed: 22153263
Biol Reprod. 2020 Feb 14;102(2):292-305
pubmed: 31616926
Theriogenology. 2011 Apr 15;75(7):1211-20
pubmed: 21247620
Mol Reprod Dev. 2015 Nov;82(11):892-7
pubmed: 26227079
J Reprod Dev. 2008 Jun;54(3):217-20
pubmed: 18277054
Methods Mol Biol. 2019;2006:115-129
pubmed: 31230276
Biol Reprod. 1997 Nov;57(5):1060-5
pubmed: 9369171
Biol Reprod. 2014 Sep;91(3):80
pubmed: 25078682
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9677-82
pubmed: 11481449
Mol Reprod Dev. 1998 Sep;51(1):53-8
pubmed: 9712317
Theriogenology. 2018 Sep 1;117:49-56
pubmed: 29859336
J Dairy Sci. 2010 Nov;93(11):5234-42
pubmed: 20965338
Biol Reprod. 2013 Dec 19;89(6):141
pubmed: 24198123
Reproduction. 2003 Sep;126(3):337-46
pubmed: 12968941
Biol Reprod. 2019 Sep 1;101(3):526-537
pubmed: 31220231
Reproduction. 2016 Dec;152(6):645-654
pubmed: 27601717

Auteurs

Froylan Sosa (F)

Department of Animal Sciences, D.H. Barron Reproductive and Perinatal Biology Research Program, and Genetics Institute, University of Florida, Gainesville, FL 32611-0910, USA.

Jeremy Block (J)

Zoetis Inc., Kalamazoo, MI 49007, USA.

Yao Xiao (Y)

Department of Animal Sciences, D.H. Barron Reproductive and Perinatal Biology Research Program, and Genetics Institute, University of Florida, Gainesville, FL 32611-0910, USA.

Peter J Hansen (PJ)

Department of Animal Sciences, D.H. Barron Reproductive and Perinatal Biology Research Program, and Genetics Institute, University of Florida, Gainesville, FL 32611-0910, USA.

Classifications MeSH